Cancer Therapy and Research Center, Institute for Drug Development

San Antonio, Texas 78229

0 studies enrolling now · 3 studies all time

What they study most

Cancer, Leukemia, Myeloid, Malignant Melanoma

Studies at this site

• Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma — Completed
• Study of XL999 in Adults With Solid Tumors — Completed
• Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia — Completed